SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0000950144-06-002099
Filing Date
2006-03-10
Accepted
2006-03-10 17:18:54
Documents
10
Period of Report
2005-12-31

Document Format Files

Seq Description Document Type Size
1 ATHEROGENICS, INC. g99853e10vk.htm 10-K 679393
2 EX-10.34 COMMERCIAL SUPPLY AGREEMENT g99853exv10w34.txt EX-10.34 100220
3 EX-10.35 LICENSE AND COLLABORATION AGREEMENT g99853exv10w35.txt EX-10.35 262549
4 EX-10.36 CO-PROMOTION AGREEMENT g99853exv10w36.txt EX-10.36 169557
5 EX-10.37 TRANSITION SERVICES AGREEMENT g99853exv10w37.txt EX-10.37 79368
6 EX-23.01 CONSENT OF ERNST & YOUNG LLP g99853exv23w01.txt EX-23.01 1034
7 EX-24.01 POWERS OF ATTORNEY g99853exv24w01.txt EX-24.01 3142
8 EX-31.1 SECTION 302, CERTIFICATION OF THE CEO g99853exv31w1.txt EX-31.1 4179
9 EX-31.2 SECTION 302, CERTIFICATION OF THE CFO g99853exv31w2.txt EX-31.2 4208
10 EX-32 SECTION 906, CERTIFICATION OF THE CEO AND CFO g99853exv32.txt EX-32 3049
  Complete submission text file 0000950144-06-002099.txt   1308153
Mailing Address
Business Address 8995 WESTSIDE PARKWAY ALPHARETTA GA 30004 6783362500
ATHEROGENICS INC (Filer) CIK: 0001107601 (see all company filings)

IRS No.: 582108232 | State of Incorp.: GA | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 000-31261 | Film No.: 06680214
SIC: 2834 Pharmaceutical Preparations